FDA authorizes Aletta robotic blood draws

The FDA authorized Vitestro’s Aletta as the first standalone robotic device that can draw blood from an adult outpatient without hands-on operator intervention, and the agency says one trained phlebotomist can supervise up to 3 units. The authorization relies on clinical data showing successful draws comparable to or better than trained phlebotomists when Aletta proceeds with a stick, with uncommon and mild device-related adverse events. Health systems should read this as a staffing multiplier that still requires a trained supervisor, alongside the archive’s evidence-first account of AI clinical workflows.